Neurostimulator output switching circuitry with self-test mode

Patent metadata

Field	Value
Publication number	US-2024278021-A1
Application number	US-202418651413-A
Country	US
Kind code	A1
Filing date	Apr 30, 2024
Priority date	Jun 23, 2021
Publication date	Aug 22, 2024
Grant date	—

Abstract

An implantable medical device (IMO) includes one or more stimulation engines (SEs) and selectively connectable output switching circuitry for driving a plurality of output nodes associated with a respective plurality of electrodes of the IMO's lead system when implanted in a patient. The output switching circuitry may be configured to facilitate self-test mode (STM) functionality in the IMO (e.g., when it is in a hermetically sealed package) by using a dual mode switch in series with a stimulation engine selection switch with respect to each output node in the output switching circuitry under mode selection control.

First claim

1 .- 16 . (canceled)

17 . A method operative with an implantable medical device (IMD), the method comprising:
establishing a machine-to-machine (M2M) communication link with an external device; responsive to a mode selection control signal received from the external device, generating one or more digital control signals for effectuating one or more internal circuit paths via output switching circuitry of the IMD by selectively activating a dual mode (DM) switch and a select stimulation engine selection (SES) switch of a plurality of SES switches associated with output nodes of the output switching circuitry, the plurality of SES switches are associated with a corresponding plurality of stimulation engines, wherein the output nodes are operative to be connected to corresponding electrodes of a lead system when implanted proximate to tissue of a patient; selectively coupling a programmable measurement circuit to at least a portion of an internal circuit path associated with a particular output node to measure at least one of an impedance of a DM switch associated with the particular output node, an impedance of a select SES switch associated with the particular output node, or programmability of a pulse current through a measurement path forming the at least a portion of the internal circuit path, wherein the DM and a particular SES switch associated with the particular output node are disposed in respective closed states forming part of the measurement path in a series connection, the pulse current having one or more configurable pulse settings and patterns selectable from the external device; and providing one or more measurements obtained from the programmable measurement circuit to the external device for presentation via a user interface.

18 . The method as recited in claim 17 , wherein the M2M communication link is established using a wireless communication protocol comprising at least one of Bluetooth Low Energy (BLE), Bluetooth, Wireless Universal Serial Bus (USB), Zigbee, Near-Field Communications (NFC), an IEEE 802.11-compliant protocol, Infrared Wireless protocol, induction wireless protocol, Medical Implant Communication Service (MICS) protocol, Wireless Medical Telemetry Service (MTS) protocol, Medical Device Radiocommunications Service (MDRS) protocol, and Medical Data Service (MDS) protocol.

19 . The method as recited in claim 17 , wherein the mode selection control signal is received from the external device comprising one of a clinician programmer device, a field technician device and an IMD manufacturer tester device.

20 . The method as recited in claim 17 , further comprising:
receiving a self-test mode (STM) disable signal from the external device; and responsive to the STM disable signal, inactivating formation of an internal circuit path in the output switching circuitry with respect to each output node of the output switching circuitry upon implanting the IMD and associated lead system in the patient.

21 . The method as recited in claim 20 , further comprising:
configuring the IMD to operate in a stimulation mode after the IMD is implanted in the patient; configuring a first electrode as an anode; coupling the first electrode to a voltage multiplier (VM) node by activating a first DM switch associated with the first electrode to be in a closed state; activating a first SES switch associated with the first electrode to be in an open state; configuring a second electrode as a cathode; activating a second DM switch associated with a second electrode to be in an open state; coupling the second electrode to a cathodic node of a particular one of the plurality of stimulation engines by activating a second SES switch associated with the second electrode to be in a closed state; and causing to energize, responsive to enabling a pulse signal, the first and second electrodes to provide stimulation therapy to the patient.

22 . The method as recited in claim 21 , further comprising:
configuring the IMD to operate in a discharge mode after providing stimulation therapy to the patient, the discharge mode involving disabling of the pulse signal; activating the first DM switch associated with the first electrode to be in an open state, thereby disconnecting the first electrode from the VM node; and activating the first SES switch associated with the first electrode to be in a closed state to couple to the cathodic node of the particular one of the plurality of stimulation engines while the second SES switch associated with the second electrode remains in the closed state, thereby continuing to maintain an electrical connection between the second electrode and the cathodic node of the particular one of the at least one stimulation engine.

23 . The method as recited in claim 21 , wherein the stimulation therapy includes at least one of a spinal cord stimulation (SCS) therapy, a neuromuscular stimulation therapy, a dorsal root ganglion (DRG) stimulation therapy, a deep brain stimulation (DBS) therapy, a cochlear stimulation therapy, a cardiac pacemaker therapy, a cardioverter-defibrillator therapy, a cardiac rhythm management (CRM) therapy, an electrophysiology (EP) mapping and radio frequency (RF) ablation therapy, an electroconvulsive therapy (ECT), a repetitive transcranial magnetic stimulation (rTMS) therapy, and a vagal nerve stimulation (VNS) therapy.

24 . A method operative with an implantable medical device (IMD), the method comprising:
establishing a machine-to-machine (M2M) communication link with an external device using a wireless communication protocol; generating an adjustable target voltage at a voltage multiplier (VM) node based on a voltage supplied by a power supply; using at least one stimulation engine operative to energize at least a portion of a plurality of electrodes of a lead system when the lead system is implanted proximate to a tissue of a patient; driving, with output switching circuitry, a plurality of output nodes, at least one output node of the plurality of output nodes is connectable to a corresponding electrode of the plurality of electrodes when implanted, the output switching circuitry comprising a switching portion for the at least one output node; selectively coupling, using a dual mode (DM) switch of the switching portion, the at least one output node to the VM node operative to power an anodic node of the at least one stimulation engine; and selectively coupling, using at least one stimulation engine selection (SES) switch, the at least one output node to a cathodic node, the DM switch and the at least one SES switch being activated to close so as to effectuate an internal circuit path in the output switching circuitry of the IMD in a self-test mode responsive to one or more digital control signals generated under control of one or more processors operating based on a mode selection control signal from the external device.

25 . The method as recited in claim 24 , wherein selectively coupling the at least one output node to the cathodic node occurs while the IMD is disposed in a sealed package condition.

26 . The method as recited in claim 24 , further comprising effectuating one or more measurement loops involving at least a portion of the internal circuit path when the IMD is in the self-test mode by using a programmable measurement circuit having selectable inputs, wherein the one or more measurement loops comprise, for respective output nodes of the output switching circuitry, a measurement path across at least one of the DM switch in a closed state or the at least one SES switch in a closed state.

27 . The method as recited in claim 26 , wherein the programmable measurement circuit is configured to measure

Assignees

• Advanced Neuromodulation Systems Inc

Inventors

• Deshazo Daran
• Rade Gavin L

Classifications

• A61N1/36038

  Cochlear stimulation · CPC title

• A61B5/367

  Electrophysiological study [EPS], e.g. electrical activation mapping or electro-anatomical mapping · CPC title

• A61N2/006

  for magnetic stimulation of nerve tissue · CPC title

• A61N1/38

  for producing shock effects · CPC title

• A61N1/362

  Heart stimulators (heart defibrillators A61N1/39) · CPC title